Showing posts with label genetics. Show all posts
Showing posts with label genetics. Show all posts
Monday, October 24, 2011
Try this at home by Daniel Grushkin
The next big scientific breakthrough may come from a garage, not a lab, with do-it-yourself biologists popping up everywhere. Genetic tinkerer Daniel Grushkin has a message for the curious: go ahead, try this at home.
In the scientific journals, we’ve been labeled biotech hobbyists, citizen scientists, even biohackers.Last December, seven of us opened the first community lab, called Genspace. Though it’s a fully functional lab, it has a decidedly hacked-together aesthetic. We built it in a Brooklyn, N.Y., warehouse that was converted into a workspace for architects and designers. At the center of the floor sits a glass cube made of found objects. The walls are created from windows and sliding glass doors saved from demo sites. The lab benches are stainless steel tables salvaged from industrial kitchens. Most of the equipment was donated by a biotech company that downsized during the economic crisis.We incorporated Genspace as a nonprofit to serve as a shared lab, a nursery for biotech tinkerers. Our members include an entrepreneur with great ideas but a miniscule budget, an artist employing single-celled organisms for an experimental design palette, a molecular biologist with a penchant for mentorship, and folks like me, who want to learn by creating novel organisms.
Wednesday, October 12, 2011
Mammalian synthetic biology: engineering of sophisticated gene networks
J Biotechnol. 2007 Jul 15;130(4):329-45. Epub 2007 May 24.
(Must subscribe to see full text)
(Must subscribe to see full text)
Abstract:
With the recent development of a wide range of inducible mammalian transgene control systems it has now become possible to create functional synthetic gene networks by linking and connecting systems into various configurations. The past 5 years has thus seen the design and construction of the first synthetic mammalian gene regulatory networks. These networks have built upon pioneering advances in prokaryotic synthetic networks and possess an impressive range of functionalities that will some day enable the engineering of sophisticated inter- and intra-cellular functions to become a reality. At a relatively simple level, the modular linking of transcriptional components has enabled the creation of genetic networks that are strongly analogous to the architectural design and functionality of electronic circuits. Thus, by combining components in different serial or parallel configurations it is possible to produce networks that follow strict logic in integrating multiple independent signals (logic gates and transcriptional cascades) or which temporally modify input signals (time-delay circuits). Progressing in terms of sophistication, synthetic transcriptional networks have also been constructed which emulate naturally occurring genetic properties, such as bistability or dynamic instability. Toggle switches which possess "memory" so as to remember transient administered inputs, hysteric switches which are resistant to stochastic fluctuations in inputs, and oscillatory networks which produce regularly timed expression outputs, are all examples of networks that have been constructed using such properties. Initial steps have also been made in designing the above networks to respond not only to exogenous signals, but also endogenous signals that may be associated with aberrant cellular function or physiology thereby providing a means for tightly controlled gene therapy applications. Moving beyond pure transcriptional control, synthetic networks have also been created which utilize phenomena, such as post-transcriptional silencing, translational control, or inter-cellular signaling to produce novel network-based control both within and between cells. It is envisaged in the not-too-distant future that these networks will provide the basis for highly sophisticated genetic manipulations in biopharmaceutical manufacturing, gene therapy and tissue engineering applications.
With the recent development of a wide range of inducible mammalian transgene control systems it has now become possible to create functional synthetic gene networks by linking and connecting systems into various configurations. The past 5 years has thus seen the design and construction of the first synthetic mammalian gene regulatory networks. These networks have built upon pioneering advances in prokaryotic synthetic networks and possess an impressive range of functionalities that will some day enable the engineering of sophisticated inter- and intra-cellular functions to become a reality. At a relatively simple level, the modular linking of transcriptional components has enabled the creation of genetic networks that are strongly analogous to the architectural design and functionality of electronic circuits. Thus, by combining components in different serial or parallel configurations it is possible to produce networks that follow strict logic in integrating multiple independent signals (logic gates and transcriptional cascades) or which temporally modify input signals (time-delay circuits). Progressing in terms of sophistication, synthetic transcriptional networks have also been constructed which emulate naturally occurring genetic properties, such as bistability or dynamic instability. Toggle switches which possess "memory" so as to remember transient administered inputs, hysteric switches which are resistant to stochastic fluctuations in inputs, and oscillatory networks which produce regularly timed expression outputs, are all examples of networks that have been constructed using such properties. Initial steps have also been made in designing the above networks to respond not only to exogenous signals, but also endogenous signals that may be associated with aberrant cellular function or physiology thereby providing a means for tightly controlled gene therapy applications. Moving beyond pure transcriptional control, synthetic networks have also been created which utilize phenomena, such as post-transcriptional silencing, translational control, or inter-cellular signaling to produce novel network-based control both within and between cells. It is envisaged in the not-too-distant future that these networks will provide the basis for highly sophisticated genetic manipulations in biopharmaceutical manufacturing, gene therapy and tissue engineering applications.
Tuesday, October 11, 2011
Registry of Standard Biological Parts
The Registry is a continuously growing collection of genetic parts that can be mixed and matched to build synthetic biology devices and systems. Founded in 2003 at MIT, the Registry is part of the Synthetic Biology community's efforts to make biology easier to engineer. It provides a resource of available genetic parts to iGEM teams and academic labs. You can register a new lab here.
The Registry sponsors international undergraduate teams (iGEM) to compete in building synthetic biology machines. This could be a good cause to make a group at university. It's another chance to boost a university's prestige and fame.
The Registry sponsors international undergraduate teams (iGEM) to compete in building synthetic biology machines. This could be a good cause to make a group at university. It's another chance to boost a university's prestige and fame.
Epigenetics
The development and maintenance of an organism is orchestrated by a set of chemical reactions that switch parts of the genome off and on at strategic times and locations. Epigenetics is the study of these reactions and the factors that influence them.
Subscribe to:
Posts (Atom)